TP
CALC icon

TritonPoint Partners’s CalciMedica CALC Stock Holding History

TritonPoint Partners’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.6K Hold
15,119
– – ﹤0.01% 351
2026
Q1 		$8.16K Hold
15,119
– – ﹤0.01% 200
2025
Q4 		$99.6K Buy
+15,119
New +$59K 0.05% 151

Other funds holding CALC

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
LGM
L1 Global Manager Melbourne $142M AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TritonPoint Partners's CALC Position: Q2 2026 in Review

TritonPoint Partners held its CalciMedica (CALC) position steady in Q2 2026 at 15,119 shares worth $15.6K. The position accounts for ﹤0.01% of the portfolio, ranked #351.

TritonPoint Partners first reported a position in CALC in Q4 2025 and has held it in 3 quarters since. The position peaked at $99.6K in Q4 2025. 31 funds tracked by Wall St. Rank hold CALC as of Q2 2026.

  • TritonPoint Partners held 15,119 shares of CalciMedica worth $15.6K as of Q2 2026.
  • TritonPoint Partners left its CalciMedica share count unchanged in Q2 2026.
  • CalciMedica made up ﹤0.01% of TritonPoint Partners's portfolio in Q2 2026, its #351 holding.
  • TritonPoint Partners first reported a position in CalciMedica in Q4 2025 and has held it in 3 quarters since.
  • TritonPoint Partners's CalciMedica position peaked at $99.6K in Q4 2025.
  • 31 funds tracked by Wall St. Rank held CalciMedica as of Q2 2026.

Based on TritonPoint Partners's 13F filing for Q2 2026, filed 13 Aug 2026.